nemu

HOME > NEWS

NEWS

Korean Intellectual Property Office Granted AskAt a Use Patent of EP4 Receptor Antagonist for the Treatment of Cartilage Disease

2021/03/23

AskAt Inc. announced today that AskAt received a notice of allowance dated March 10, 2021 from the Korean Intellectual Property Office in connection with the Application No. 10-2020-7024372, a use patent of EP4 receptor antagonist for the treatment of cartilage disease.

PAGE TOP

Menu